查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087808

局部止血劑市場：2026-2032年全球市場預測（依產品類型、配方、材料來源、吸收、應用、最終用戶和通路分類）

Topical Hemostat Market by Product Type, Formulation, Material Source, Absorbability, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，局部止血劑市場規模將成長至 115.1 億美元，複合年成長率為 8.06%。

主要市場統計數據
基準年 2025 66.9億美元
預計年份：2026年 72億美元
預測年份：2032年 115.1億美元
複合年成長率 (%) 8.06%

局部止血劑市場概況

局部止血劑是外科止血產品中的重要類別，用於傳統止血技術（如壓迫、縫合、夾閉、電燒和結紮）效果不佳或不切實際的情況。此市場包括可吸收機械止血劑、活性凝血酶類產品、液體止血基質、纖維蛋白膠、合成密封劑和複合產品，廣泛應用於心血管外科、整形外科、神經外科、一般外科、創傷外科、產科和微創手術。

一項將重塑局部止血療法的變革性變革。

局部止血劑市場正從通用型手術輔助用品轉向特定手術、基於實證醫學的止血解決方案。外科醫生越來越傾向於根據出血強度、解剖結構限制、吸收性、膨脹特性、劑型以及與微創機器人手術流程的兼容性來選擇產品。這種轉變使得即用型液體止血劑、噴霧密封劑以及專為狹窄和難以觸及的手術區域設計的施用器越來越受到關注。

人工智慧對局部止血劑的累積影響

人工智慧 (AI) 正透過需求預測、證據整合、生產最佳化、品質監控和臨床決策支援等方式，開始影響局部止血劑的價值鏈。在醫院中，AI 驅動的分析可以識別手術類型、外科醫生偏好、輸血風險和產品使用情況的差異，從而幫助供應鏈團隊在不影響臨床選擇的前提下實現配方標準化。

局部止血劑需求的關鍵區域性見解。

北美地區憑藉其先進的外科手術基礎設施、生物來源和複合止血劑的高滲透率、完善的血液管理實踐以及醫院對FDA批准或已獲批准產品的重視，仍然是局部止血劑的高價值市場。歐洲的特點是外科手術需求成熟、許多國家實施集中採購，以及歐盟醫療設備法規（MDR），這提高了臨床文件、上市後監測、可追溯性和真實世界資料（RWE）的重要性。

用於策略市場定位的關鍵群體分析

在區域集團內部，七國集團（G7）憑藉其高手術頻率、完善的醫保報銷機制、先進的手術室基礎設施以及嚴格的產品評估，引領著高階局部止血劑的普及應用。歐盟（EU）的影響力不容小覷，因為遵守歐盟醫療器材法規（EU MDR）不僅影響成員國，也影響全球製造商，他們利用帶有CE標誌的產品系列進行國際註冊和採購。北約市場與高所得國家的醫療保健系統高度重疊，在這些國家，手術應對力、創傷管理、緊急準備和供應韌性都是策略重點。

首選局部止血劑市場的關鍵國家洞察

美國擁有龐大的手術量、完善的專科醫療體系、醫院血液管理項目以及成熟的FDA監管止血劑核准管道，因此為先進局部止血劑提供了最大的商業性機會。在加拿大，人們更注重實證醫學、安全性、醫療技術評估以及省級採購規範。同時，墨西哥私立醫院的蓬勃發展和公共部門成本意識的提高，共同推動了這個市場的發展。巴西憑藉其三級醫療體系和複雜的手術量，在拉丁美洲局部止血劑市場佔據領先地位，但報銷機制和競標趨勢的差異正在影響其應用。

局部止血劑產業領導者使用的實用建議

產業領導企業應優先考慮差異化的臨床證據，這些證據應能證明局部止血劑的療效與減少出血相關併發症、避免輸血、縮短手術時間、簡化工作流程以及降低整體醫療成本密切相關。產品系列應根據出血嚴重程度、手術類型、給藥途徑、吸收情況、腫脹風險和配製時間進行細分，從而使醫院能夠在不影響複雜出血治療的情況下，實現產品選擇的標準化。

調查方法與證據框架

本執行摘要基於系統的二手研究方法，利用公開且檢驗的資訊來源，包括監管資料庫、產品標籤、臨床文獻、醫院血液管理指南、公共衛生統計數據、報銷標準、採購趨勢以及來自權威機構的宏觀經濟研究途徑。市場分析涵蓋產品分類、外科應用、監管環境、區域供應、採購趨勢和競爭定位。

結論：局部止血劑的策略性展望

隨著外科團隊對更快、更安全、更最佳化手術效果的止血方案的需求日益成長，局部止血劑市場預計將保持其重要的戰略地位。競爭優勢不僅取決於產品供應，還需具備清晰的臨床差異化、可靠的供應、便於外科醫師使用的給藥方法、符合監管要求，以及能夠證明其整體成本效益的證據。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：局部止血劑市場：依產品類型分類

  • 機械止血裝置
    • 明膠基
    • 膠原蛋白蛋白
    • 氧化再生纖維素
    • 多醣
  • 活性止血劑
  • 液體止血劑
  • 腐蝕性止血劑
    • 硝酸銀
    • 亞硫酸亞鐵
    • 氯化鋁

第8章：局部止血劑市場：以劑型分類

  • 海綿
  • 粉末
  • 座位
  • 軟墊
  • 氣泡劑
  • 凝膠

第9章：局部止血劑市場：依材料來源分類

  • 生物基材料
  • 植物來源材料
  • 合成材料

第10章：局部止血劑市場：吸收型

  • 可吸收止血劑
  • 不被吸收的止血劑

第11章：局部止血劑市場：依應用領域分類

  • 心血管外科
    • 冠狀動脈繞道手術手術
    • 閥門維修和更換
    • 血管移植
  • 牙科和口腔外科
    • 拔牙
    • 牙周手術
    • 植入植入
  • 一般外科
    • 腹部
    • 消化器官系統
    • 肝膽系統
    • 冒號
  • 神經外科
    • 顱內
    • 脊椎神經外科
    • 切除術
  • 整形外科手術
    • 關節重建手術
    • 脊椎
  • 婦科手術
    • 子宮切除術
    • 子宮肌瘤切除手術
    • 子宮內膜異位症

第12章：局部止血劑市場：依最終用戶分類

  • 門診手術中心
  • 專科診所
  • 醫院
    • 私立醫院
    • 公立醫院
  • 軍事/國防
  • 居家照護

第13章：局部止血劑市場：依通路分類

  • 線上
  • 離線

第14章：局部止血劑市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：局部止血劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：局部止血劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.
Product Code: MRR-031AB52F47EB

The Topical Hemostat Market is projected to grow by USD 11.51 billion at a CAGR of 8.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.69 billion
Estimated Year [2026] USD 7.20 billion
Forecast Year [2032] USD 11.51 billion
CAGR (%) 8.06%

Executive Introduction to the Topical Hemostat Market

Topical hemostats are an essential category of surgical bleeding control products used when conventional techniques such as pressure, sutures, clips, cautery, or ligation are insufficient or impractical. The market spans absorbable mechanical agents, active thrombin-based products, flowable hemostatic matrices, fibrin sealants, synthetic sealants, and combination products used across cardiovascular, orthopedic, neurosurgical, general, trauma, obstetric, and minimally invasive procedures.

Demand is supported by persistent surgical volume, population aging, rising comorbidity burden, wider use of anticoagulant and antiplatelet therapies, and the clinical priority of reducing blood loss, transfusion exposure, operating-room time, and postoperative complications. For manufacturers, hospitals, and investors, competitive advantage is increasingly tied to proven hemostatic performance, fast preparation, biocompatibility, transparent total-cost evidence, and regulatory compliance across major markets.

Transformative Shifts Reshaping Topical Hemostasis

The topical hemostat landscape is moving from commodity surgical adjuncts toward procedure-specific, evidence-led bleeding control solutions. Surgeons increasingly select products based on bleeding intensity, anatomical constraints, absorbability, swelling profile, delivery format, and compatibility with minimally invasive and robotic workflows. This shift favors ready-to-use flowables, sprayable sealants, and applicators designed for narrow or difficult-to-access surgical fields.

Regulatory expectations are also transforming the market. The U.S. FDA treats many thrombin, fibrin, and combination hemostats as biologics, devices, or combination products depending on composition and claims, while the European Union Medical Device Regulation has increased clinical evidence, post-market surveillance, and documentation requirements. As a result, suppliers with robust clinical data, validated quality systems, and reliable plasma, collagen, gelatin, cellulose, or synthetic polymer sourcing are better positioned than firms competing primarily on price.

Cumulative Impact of Artificial Intelligence on Topical Hemostats

Artificial intelligence is beginning to influence the topical hemostat value chain through demand planning, evidence synthesis, manufacturing optimization, quality monitoring, and clinical decision support. In hospitals, AI-enabled analytics can identify procedure types, surgeon preference patterns, transfusion risk, and product utilization variance, helping supply-chain teams standardize formularies without compromising clinical choice.

For manufacturers, machine learning can improve batch consistency, predict raw-material deviations, monitor sterilization and packaging quality, and accelerate post-market surveillance by analyzing complaint trends, adverse-event narratives, and real-world safety signals. AI does not replace surgeon judgment at the point of bleeding control, but it can make product selection, inventory planning, clinical education, and health-economic evidence more precise, especially where hospitals are under pressure to reduce waste and prove value.

Key Regional Insights Across Topical Hemostat Demand

North America remains a high-value region for topical hemostats because of advanced surgical infrastructure, strong adoption of biologic and combination hemostats, established blood-management practices, and hospital focus on FDA-cleared or FDA-approved products. Europe is shaped by mature surgical demand, centralized procurement in many countries, and the EU MDR, which has raised the importance of clinical documentation, post-market surveillance, traceability, and real-world evidence.

Asia-Pacific is an expanding opportunity base, driven by rising surgical access, private hospital investment, medical tourism, and growing domestic medtech capacity across China, India, Japan, South Korea, Australia, and ASEAN economies. Latin America, led by Brazil and Mexico, shows increasing demand in tertiary hospitals and private networks but remains sensitive to reimbursement, tender pricing, and currency volatility. The Middle East is supported by specialty hospital investment, trauma and complex-care capabilities, and GCC healthcare modernization, while Africa offers long-term potential through trauma care, maternal health, and surgical-capacity expansion, although affordability, training, cold-chain needs for some biologic products, and distribution reliability remain key constraints.

Key Group Insights for Strategic Market Positioning

Among regional blocs, the G7 anchors premium topical hemostat adoption through high procedure intensity, established reimbursement pathways, advanced operating-room infrastructure, and stringent product evaluation. The European Union is influential because EU MDR compliance affects not only member states but also global manufacturers that use CE-marked portfolios for international registration and procurement access. NATO markets overlap significantly with high-income healthcare systems where surgical readiness, trauma management, emergency preparedness, and supply resilience are strategic priorities.

BRICS economies represent a dual opportunity: China, India, and Brazil are expanding access to advanced surgery, while domestic production, tender discipline, and cost containment increasingly shape procurement. ASEAN is important for medical tourism, private hospital chains, and improving surgical infrastructure in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is a premium regional cluster where hospital modernization, specialist centers, government-funded healthcare investment, and international accreditation support adoption of advanced hemostatic products when supported by clinical and economic evidence.

Key Country Insights in Priority Topical Hemostat Markets

The United States is the largest commercial opportunity for advanced topical hemostats because of high surgical intensity, strong specialty care, hospital blood-management initiatives, and established pathways for FDA-regulated hemostatic agents. Canada emphasizes evidence, safety, health technology assessment, and provincial procurement discipline, while Mexico combines private hospital growth with public-sector cost sensitivity. Brazil is Latin America's leading topical hemostat market, supported by tertiary care capacity and complex surgery, although reimbursement variability and tender dynamics affect uptake.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show mature demand shaped by hospital value committees, clinical guidelines, national reimbursement structures, and EU MDR-related evidence requirements, while Russia remains affected by localization, procurement, and geopolitical supply considerations. China and India offer substantial growth as surgical access expands, but pricing, volume-based purchasing, tenders, and local competition are decisive. Japan and South Korea are quality-focused markets with advanced surgical adoption and strict regulatory expectations, while Australia rewards products that demonstrate safety, usability, supply reliability, and measurable value within a well-regulated healthcare system.

Actionable Recommendations for Topical Hemostat Leaders

Industry leaders should prioritize differentiated clinical evidence that links topical hemostat performance to reduced bleeding-related complications, transfusion avoidance, shorter procedure time, improved workflow efficiency, and lower total cost of care. Product portfolios should be segmented by bleeding severity, procedure type, access route, absorbability, swelling risk, and preparation time so hospitals can standardize selection without under-treating complex bleeding.

Manufacturers should strengthen supply-chain resilience for human plasma, bovine, porcine, cellulose, gelatin, collagen, and synthetic inputs while investing in applicator innovation for minimally invasive and robotic surgery. Commercial teams should equip value-analysis committees with real-world evidence, budget-impact models, comparative usability data, and surgeon education. Regulatory teams should align early with FDA, EU MDR, and local requirements to avoid launch delays, documentation gaps, and post-market surveillance deficiencies.

Research Methodology and Evidence Framework

This executive summary is based on a structured secondary-research approach using publicly available and verifiable sources, including regulatory databases, product labeling, clinical literature, hospital blood-management guidance, public health statistics, reimbursement references, procurement signals, and macroeconomic indicators from recognized institutions. Market interpretation considers product class, surgical application, regulatory status, regional access, procurement behavior, and competitive positioning.

Insights are triangulated across clinical evidence, regulatory context, healthcare infrastructure, and commercial adoption signals. The methodology excludes unsupported claims, market sizing, market share, and forecasting, and emphasizes data-backed patterns such as surgical access expansion, aging demographics, increased anticoagulant use, regulatory scrutiny, hospital demand for value-based procurement, and the growing role of real-world evidence in medical product evaluation.

Conclusion: Strategic Outlook for Topical Hemostats

The topical hemostat market is positioned for sustained strategic relevance as surgical teams seek faster, safer, and more procedure-specific bleeding control. Competitive success will depend on more than product availability; it will require clear clinical differentiation, reliable supply, surgeon-friendly delivery, regulatory readiness, and evidence that supports total-cost value.

As AI, advanced biomaterials, minimally invasive surgery, and stricter regulatory expectations reshape the category, manufacturers that combine innovation with real-world outcomes data will be best placed to earn hospital trust. Regional expansion remains attractive, but durable growth will come from aligning premium performance with local reimbursement, procurement expectations, surgical workflow realities, and patient-safety priorities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Topical Hemostat Market, by Product Type

  • 7.1. Mechanical Hemostats
    • 7.1.1. Gelatin-based
    • 7.1.2. Collagen-based
    • 7.1.3. Oxidized Regenerated Cellulose
    • 7.1.4. Polysaccharide-based
  • 7.2. Active Hemostats
  • 7.3. Flowable Hemostats
  • 7.4. Caustic Hemostats
    • 7.4.1. Silver Nitrate
    • 7.4.2. Ferric Subsulfate
    • 7.4.3. Aluminum Chloride

8. Topical Hemostat Market, by Formulation

  • 8.1. Sponges
  • 8.2. Powders
  • 8.3. Sheets
  • 8.4. Pads
  • 8.5. Foams
  • 8.6. Gels

9. Topical Hemostat Market, by Material Source

  • 9.1. Biological Materials
  • 9.2. Plant-derived Materials
  • 9.3. Synthetic Materials

10. Topical Hemostat Market, by Absorbability

  • 10.1. Absorbable Hemostats
  • 10.2. Non-Absorbable Hemostats

11. Topical Hemostat Market, by Application

  • 11.1. Cardiovascular Surgery
    • 11.1.1. Coronary Artery Bypass Grafting
    • 11.1.2. Valve Repair & Replacement
    • 11.1.3. Vascular Grafting
  • 11.2. Dental & Oral Surgery
    • 11.2.1. Tooth Extraction
    • 11.2.2. Periodontal Surgery
    • 11.2.3. Implant Placement
  • 11.3. General Surgery
    • 11.3.1. Abdominal
    • 11.3.2. Gastrointestinal
    • 11.3.3. Hepatobiliary
    • 11.3.4. Colorectal
  • 11.4. Neurosurgery
    • 11.4.1. Cranial
    • 11.4.2. Spinal Neurosurgery
    • 11.4.3. Tumor Resection Procedures
  • 11.5. Orthopedic Surgery
    • 11.5.1. Joint Replacement
    • 11.5.2. Spine
  • 11.6. Gynecological Surgery
    • 11.6.1. Hysterectomy
    • 11.6.2. Myomectomy
    • 11.6.3. Endometriosis

12. Topical Hemostat Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Specialty Clinics
  • 12.3. Hospitals
    • 12.3.1. Private Hospitals
    • 12.3.2. Public Hospitals
  • 12.4. Military & Defense Settings
  • 12.5. Homecare Settings

13. Topical Hemostat Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Topical Hemostat Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Topical Hemostat Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Topical Hemostat Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Aegis Lifesciences Private Limited
  • 18.2. Axio Biosolutions Pvt Ltd
  • 18.3. B.Braun Melsungen AG
  • 18.4. Baxter International, Inc.
  • 18.5. Becton, Dickinson and Company
  • 18.6. Betatech Medical
  • 18.7. BioCer Entwicklungs-GmbH
  • 18.8. Bristol-Myers Squibb Company
  • 18.9. Dilon Technologies Inc
  • 18.10. GELITA MEDICAL GmbH
  • 18.11. Hemostasis, LLC
  • 18.12. Integra LifeSciences Corporation
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. Marine Polymer Technologies, Inc.
  • 18.15. Medline Industries, LP
  • 18.16. Medtrade Products Ltd
  • 18.17. Medtronic PLC
  • 18.18. Meril Life Sciences Pvt. Ltd
  • 18.19. Pfizer Inc.
  • 18.20. Southmedic Inc.
  • 18.21. Stryker Corporation
  • 18.22. SYMATESE SAS
  • 18.23. Takeda Pharmaceutical Company Limited
  • 18.24. Teleflex Incorporated
  • 18.25. Zeria Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TOPICAL HEMOSTAT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TOPICAL HEMOSTAT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MECHANICAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GELATIN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GELATIN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GELATIN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYSACCHARIDE-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ACTIVE HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLOWABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAUSTIC HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SILVER NITRATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SILVER NITRATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SILVER NITRATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FERRIC SUBSULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALUMINUM CHLORIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPONGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPONGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHEETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SHEETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHEETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT-DERIVED MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ABSORBABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-ABSORBABLE HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VALVE REPAIR & REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VASCULAR GRAFTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DENTAL & ORAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TOOTH EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIODONTAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IMPLANT PLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GENERAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GENERAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENERAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ABDOMINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ABDOMINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ABDOMINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEPATOBILIARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEPATOBILIARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEPATOBILIARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL COLORECTAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL COLORECTAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL COLORECTAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CRANIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CRANIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CRANIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SPINAL NEUROSURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TUMOR RESECTION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SPINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SPINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SPINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HYSTERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HYSTERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HYSTERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MYOMECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MYOMECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MYOMECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MILITARY & DEFENSE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. GCC TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. GCC TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 298. GCC TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 299. GCC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 300. GCC TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 302. GCC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. GCC TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 304. GCC TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 305. GCC TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 306. GCC TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 307. GCC TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 308. GCC TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 309. GCC TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. GCC TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. GCC TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPEAN UNION TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 341. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 345. BRICS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 346. G7 TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. G7 TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. G7 TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 349. G7 TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 350. G7 TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 351. G7 TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 352. G7 TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 353. G7 TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 354. G7 TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 355. G7 TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 356. G7 TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 357. G7 TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 358. G7 TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 359. G7 TOPICAL HEMOSTAT MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 360. G7 TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 361. G7 TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 362. G7 TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 363. NATO TOPICAL HEMOSTAT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. NATO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. NATO TOPICAL HEMOSTAT MARKET SIZE, BY MECHANICAL HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 366. NATO TOPICAL HEMOSTAT MARKET SIZE, BY CAUSTIC HEMOSTATS, 2018-2032 (USD MILLION)
  • TABLE 367. NATO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 368. NATO TOPICAL HEMOSTAT MARKET SIZE, BY MATERIAL SOURCE, 2018-2032 (USD MILLION)
  • TABLE 369. NATO TOPICAL HEMOSTAT MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 370. NATO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 371. NATO TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 372. NATO TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL & ORAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 373.